Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
More Reading from MarketBeat Media 3 ETFs Catapulting Beyond the S&P to Start the YearAuthored by Nathan Reiff. Published: 1/29/2026. 
At a Glance - A month into 2026, several standout ETFs are separating from the broader market—driven by niche themes beyond the usual mega-cap tech trade.
- Top performers include a pure-play drone ETF and a nickel miners fund, reflecting investor appetite for defense tech and EV-linked metals.
- A covered-call income ETF tied to Moderna is also surging, but its strategy trades upside potential for high distributions and adds complexity risk.
A month into 2026, exchange-traded funds (ETFs) are accumulating enough performance data to begin distinguishing themselves from the broader market. Some of this year's top-performing funds may surprise investors. Beyond leveraged funds—designed for short-term trading—and ETFs lifted by the recent gold and silver rallies, several standout ETFs focus on drone technology, nickel mining and covered-call strategies. Pure-Play Drone Exposure at a Pivotal Time for the Industry Gold has weathered every financial disaster in history, and it's up more than 100 percent in the last two years. But there's another reason to pay attention now. Since 1950, roughly 70 percent of all the gold on earth has already been mined. What remains is harder to find and more costly to extract. Supplies are running out at the exact moment the world needs gold to stabilize heavily indebted financial systems. A four-stock portfolio of top gold developers is now available, selling at an average 82 percent discount to asset value. Get the four picks plus a bonus stock with potential for significant upside. By combining AI and unmanned aerial vehicle (UAV) systems, drone companies have the potential to transform defense, infrastructure, agriculture and other industries. Increasingly, ETFs offer targeted ways to gain exposure to this rapid growth, and the REX Drone ETF (NASDAQ: DRNZ), launched in October 2025, is one of the newest options. DRNZ is notable as the only pure-play drone ETF with global exposure, giving investors access as UAV technology expands beyond military and defense applications into commercial and industrial uses. Its portfolio is relatively concentrated—43 holdings—with major names such as Ondas Inc. (NASDAQ: ONDS) and DroneShield Ltd. (ASX: DRO) among the largest positions. The top three holdings make up roughly a third of the fund, so investors should check for overlap with any individual drone stocks they already own to avoid overexposure. DRNZ carries an expense ratio of 0.65% and has returned nearly 30% so far in 2026. Because it is a very new fund, assets under management and trading volume are relatively low, which could present liquidity considerations. Off-the-Beaten-Path Metals Fund With International Focus and Excellent Returns Amid the attention on gold and silver, investors may overlook other precious metals opportunities. The Sprott Nickel Miners ETF (NASDAQ: NIKL) is one such alternative, offering exposure to companies mining a key metal for electric vehicles (EVs) and nickel-zinc (NiZn) batteries. Nickel can increase energy density in EV batteries and help extend driving range, a dynamic that could support rising nickel demand. In a crowded metals ETF landscape, NIKL is the only pure-play nickel miner fund. It holds 27 global mining companies, primarily small- and mid-cap firms operating in nickel-rich regions such as Indonesia, Australia and Canada. That international focus gives U.S. investors access to often-overlooked miners outside the domestic market. NIKL's expense ratio is 0.75%. In return for that cost, the fund has delivered strong performance — nearly 31% year-to-date and about 94% over the past 12 months — along with a dividend yield of 1.80%. Unique Covered Call Strategy on Moderna Has Paid Off The YieldMax MRNA Option Income Strategy ETF (NYSEARCA: MRNY) follows a specialized covered-call strategy aimed at generating weekly income using shares of biotech company Moderna Inc. (NASDAQ: MRNA). With an annual distribution of $19.15 — a yield of 92.16% — MRNY has been effective at producing high income over its two-plus years of operation. MRNY also participates in upside when MRNA rises because the ETF maintains long exposure to the stock. MRNA's roughly 55% year-to-date gain has helped drive MRNY's approximately 47% return since the start of 2026. Investors should note, however, that the covered-call structure caps some upside, so MRNY's capital appreciation will not perfectly mirror the underlying stock's gains. MRNY is a niche, specialized fund that may appeal mainly to sophisticated investors; its 1.27% expense ratio reflects that orientation. Still, the ETF has delivered a notable mix of distributions and capital appreciation recently and could continue to perform well if Moderna remains strong.
| 
0 Response to "We're excited to have you on board"
Post a Comment